MeCRU Research Unit (MeCRU), at SMU has been officially launched as the research site for Phase III Paediatric COVID-19 Vaccine study conducted by the Numolux Group and Sinovac on 10 September 2021. The very first child and the second one had the honor to receive their jabs which kick started the study.
SMU hosts SAHDIA advancing HDI future
Sefako Makgatho Health Sciences University (SMU) took centre stage in advancing the future of Historically Disadvantaged Institutions (HDIs) as it hosted the 7th Networking Workshop of the South African Historically Disadvantaged Institutions Alliance (SAHDIA) from...
